Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | Director · Chairman, President & CEO | February 11, 2026 | February 13, 2026 |
| PENTAIR plcPNR · Entity 3537 | Director | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,373 |
Ending reported balance
After 2026-02-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-11 · Grant · Acquired 7,350 · Balance 83,284 F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Row 2 · 2026-02-11 · Grant · Acquired 18,291 · Balance 101,575 F2: Represents the vesting of performance stock units (includes 306 dividend equivalent shares) for the 2023-2025 performance period. Row 3 · 2026-02-11 · Tax withholding · Disposed 9,358 · Balance 92,217 F3: 9,358 of the 18,291 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Row 4 · 2026-02-12 · Tax withholding · Disposed 844 · Balance 91,373 F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $178.68 · Expires 2036-02-11 | Direct | 26,900 |
Reported balance
After 2026-02-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-02-11 · Grant · Acquired 26,900 · Balance 26,900 F6: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 2,007 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 2,007 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 1,022.58 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1,022.58 F5: Reflects securities held in a trust for the benefit of the Reporting Person's mother and for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership over the securities held by the trust, except to the extent of his pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Represents the vesting of performance stock units (includes 306 dividend equivalent shares) for the 2023-2025 performance period.
F3: 9,358 of the 18,291 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
F5: Reflects securities held in a trust for the benefit of the Reporting Person's mother and for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership over the securities held by the trust, except to the extent of his pecuniary interest therein, if any.
F6: Options vest 20% Year 1, 40% Year 2, and 40% Year 3.
PENTAIR plc
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - Restricted Stock UnitsSEC Table I · non-derivative | Direct | 1,564 |
Reported balance
After 2026-01-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 1,564 · Balance 1,564 F1: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). F3: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. |
| Common StockSEC Table I · non-derivative | Direct | 15,347 |
Reported balance
After 2026-01-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-01-02 · Tax withholding · Disposed 689 · Balance 15,347 F4: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F3: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting.
F2: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).
F3: End-of-period holdings reflect the vesting of restricted stock units that were previously reported.
F4: Shares surrendered to pay taxes applicable to vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2022 Filed Feb 14, 2022 13:53 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 5,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005085 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,659 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:59 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Shares - Restricted Stock Units | 2,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-000332 · doc1.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,862.352 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2 · balance_after: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 21,900 | $0.00 Strike: $119.13 | $0.00 |
DisclosureSEC source: 0001140361-21-005115 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,780 Underlying: Common Stock · 21,900 shares Expires 2031-02-11 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:50 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 4,825 | $119.13 | $574,802.25 |
DisclosureSEC source: 0001140361-21-005115 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,538 F3 · shares: 4,825 of the 9,840 shares that vested February 11, 2021 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 9,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-005115 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,363 F2 · shares: Acquired upon the settlement of performance shares granted on February 15, 2018 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 6,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-005115 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,523 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:10 UTC | PENTAIR plc PNR · Entity 3537 | Tax withholdingCommon Shares | 133 | $51.53 | $6,853.49 |
DisclosureSEC source: 0001567619-21-000620 · doc1.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,877 F3 · kind: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F2 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:10 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Shares - Restricted Stock Units | 2,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-000620 · doc1.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,717 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2020 Share and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:23 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 24,500 | $0.00 Strike: $111.92 | $0.00 |
DisclosureSEC source: 0001140361-20-003537 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,880 Underlying: Common Stock · 24,500 shares Expires 2030-02-13 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:23 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,147 | $111.49 | $239,369.03 |
DisclosureSEC source: 0001140361-20-003537 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,255 F3 · shares: 2,114 of the 4,371 shares that vested February 13, 2020 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:23 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 4,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-003537 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,402 F2 · shares: Acquired upon the settlement of performance shares granted on February 21, 2017 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:23 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 5,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-003537 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,031 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:21 UTC | PENTAIR plc PNR · Entity 3537 | Tax withholdingCommon Shares | 1,430 | $46.42 | $66,380.60 |
DisclosureSEC source: 0001567619-20-000610 · doc1.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,994 F3 · kind: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F2 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:21 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Shares - Restricted Stock Units | 3,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-000610 · doc1.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,016 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2012 Stock and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. F2 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:42 UTC | PENTAIR plc PNR · Entity 3537 | Tax withholdingCommon Shares | 1,145 | $38.99 | $44,643.55 |
DisclosureSEC source: 0001567619-19-009871 · doc1.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,717 F1 · kind: Shares surrendered to pay taxes applicable to vesting of restricted stock units. F2 · balance_after: End-of-period holdings reflect the vesting of restricted stock units that were previously reported. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:20 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 28,300 | $0.00 Strike: $84.09 | $0.00 |
DisclosureSEC source: 0001140361-19-003362 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,316 Underlying: Common Stock · 28,300 shares Expires 2029-02-13 F4 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:20 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,591 | $84.09 | $217,877.19 |
DisclosureSEC source: 0001140361-19-003362 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,565 F3 · shares: 2,552 of the 5,128 shares that vested February 13, 2019 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:20 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 5,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003362 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,156 F2 · shares: Acquired upon the settlement of performance shares granted on February 22, 2016 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:20 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 6,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003362 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,950 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:54 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Shares - Restricted Stock Units | 3,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-000580 · doc1.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,569 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2012 Stock and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. Read SEC document |
| May 02, 2018 Filed May 4, 2018 22:04 UTC | PENTAIR plc PNR · Entity 3537 | GrantCommon Shares - Restricted Stock Units | 2,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-021797 · doc1.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,862 F1 · kind: Restricted stock units granted pursuant to and subject to a vesting condition of the Pentair plc 2012 Stock and Incentive Plan. Each restricted stock unit represents a right to receive one Pentair plc share upon vesting. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:47 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 18,800 | $0.00 Strike: $74.57 | $0.00 |
DisclosureSEC source: 0001140361-18-009169 · form4.xml · derivative · entry 4 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,800 Underlying: Common Stock · 18,800 shares Expires 2028-02-15 F4 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:47 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 3,152 | $74.57 | $235,044.64 |
DisclosureSEC source: 0001140361-18-009169 · form4.xml · nonDerivative · entry 3 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,842 F3 · shares: 3,152 of the 6,450 shares that vested February 15, 2018 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:47 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 6,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009169 · form4.xml · nonDerivative · entry 2 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,994 F2 · shares: Acquired upon the settlement of performance shares granted on February 19, 2018 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:47 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 4,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009169 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,544 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| April 28, 2017 Filed May 4, 2017 14:31 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 13,924 | $81.16 | $1,130,071.84 |
DisclosureSEC source: 0001140361-17-018372 · doc1.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,688 F1 · shares: On April 28, 2015, the Company granted 54,000 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Issuer and to restrictions on transfer until 50% of the restricted shares vested in accordance with the provisions of the Restricted Stock Purchase Agreements on April 28, 2017. 13,924 of the 27,000 shares that vested April 28, 2017 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:24 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantEmployee Stock Option (right to buy) · Derivative | 25,930 | $0.00 Strike: $85.40 | $0.00 |
DisclosureSEC source: 0001140361-17-008928 · doc1.xml · derivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,930 Underlying: Common Stock · 0 shares Expires 2027-02-21 F1 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.